Business Wire

Tradeweb is Authorised by Dutch Regulator to Operate from Amsterdam

15.1.2019 11:15:00 EET | Business Wire | Press release

Share

Tradeweb Markets, a leading global marketplace for electronic fixed income, derivatives and ETF trading, announced that its new legal entity in the Netherlands, Tradeweb EU B.V, has received authorisation from the Dutch Authority for the Financial Markets (AFM) to operate Trading Venues and an Approved Publication Arrangement (APA) from Amsterdam.

The authorisation mirrors Tradeweb’s current regulatory permissions in the United Kingdom, ensuring the firm is positioned to offer the same range of services, products and execution protocols within the EU27 and in the UK, following the latter’s withdrawal from the European Union (Brexit). Firms signing up to the regulated platforms offered by Tradeweb EU B.V. will benefit from a streamlined onboarding process, and, clients will also be able to connect to the new platforms for testing well in advance of March 29, 2019, the expected Brexit date.

“We are pleased to be granted authorised status for the provision of trading and reporting services from Amsterdam,” said Enrico Bruni, head of Europe and Asia business at Tradeweb. “We remain focused on ensuring that our clients continue to benefit from seamless and uninterrupted access to liquidity post- Brexit, which is anticipated to have a profound impact within the financial markets. Helping our clients in the EU to seamlessly on-board to our new regulated platforms quickly and effectively is our top priority, and we are already seeing firms engage early and sign up to the Tradeweb EU MTF."

Tradeweb established its post-Brexit EU headquarters in Amsterdam last year, in recognition of the city’s robust infrastructure and the Dutch regulator’s long expertise in financial services. The new office acts as the electronic execution venue for Tradeweb’s EEA-based clients, while being an integral part of the firm’s global network, including New York, Chicago, London, Tokyo, Hong Kong, Singapore and Shanghai.

In addition to operating an MTF, an OTF and an APA from London, Tradeweb has regulated status in a number of jurisdictions in Asia-Pacific, including as an Automated Trading Services (ATS) operator in Hong Kong, a Recognised Market Operator (RMO) in Singapore, and an Electronic Trading Platform (ETP) in Japan, where it also holds a Proprietary Trading System (PTS) Operator License. Furthermore, Tradeweb operates two CFTC-regulated Swap Execution Facilities (SEFs) and offers regulated markets through three SEC-registered broker dealers in the US.

About Tradeweb Markets

Tradeweb Markets LLC is a leading global operator of electronic marketplaces for fixed income, derivatives and ETFs. Founded in 1996, the company provides access to markets, data and analytics, electronic trading, straight-through-processing and reporting for more than 40 products to clients in the institutional, wholesale and retail markets. Advanced technologies developed by Tradeweb enhance price discovery, order execution and trade workflows, while allowing for greater scale and reduced risks in client trading operations. The company serves approximately 2,500 clients in more than 60 countries. In an average trading day, Tradeweb facilitates more than $540 billion in notional value. For more information, please go to www.tradeweb.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Susan Bennett
+44 (0)20 3749 3316
Susan.Bennett@tradeweb.com

Angeliki Kallipoliti
+44 (0)20 7776 0958
Angeliki.Kallipoliti@tradeweb.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Imagine Dragons to Perform at Abu Dhabi Grand Prix21.5.2026 18:51:00 EEST | Press release

Ethara, organiser of the Formula 1 Etihad Airways Abu Dhabi Grand Prix, have announced that one of the world’s biggest bands, Imagine Dragons, will headline the Saturday After-Race Concerts at the F1 Season Finale in Abu Dhabi. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521214839/en/ Imagine Dragons to perform at Formula 1 Etihad Airways Abu Dhabi Grand Prix (Photo: AETOSWire) The announcement is another landmark moment for the Abu Dhabi Grand Prix, whose thrilling Yasalam presented by e& fan entertainment offering has become synonymous with the F1 Championship finale in Abu Dhabi and is recognised as one of the most compelling sports and entertainment crossovers globally. The global chart-toppers join Lewis Capaldi and Zara Larsson, who are set to kick off a blockbuster line-up of performances on Yas Island on Thursday, 3 December, with more major international artists to be revealed. With their popular top hits, Ima

Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 17:25:00 EEST | Press release

Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensuring your investment is delivering.” The rapid growth of the residential solar market created a growing population of “orphaned” solar sy

Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 15:05:00 EEST | Press release

A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is designed to interpret cardiac MRI scans by connecting moving images of the heart with corresponding clinical radio

The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 15:00:00 EEST | Press release

Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The research challenges long-held assumptions about media value, showing that not all impressions are equal. Live sports rem

Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 15:00:00 EEST | Press release

Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer cell killing activity,” said David Weinreich, MD, MBA, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck. “The Phase 3 study and the enrollment of the first patient with Precem-TcT build on the Company’s more than 20 years of expertise in colorectal cancer, and highlight our commitment to advancing differentiated ADCs for heavily pretreated patients with limited treatment options.” The PROCEADE®-CRC-03 study

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye